Literature DB >> 24007651

Current concepts in the surgical management of primary glenohumeral arthritis with a biconcave glenoid.

Patrick J Denard1, Gilles Walch.   

Abstract

Glenoid morphology has an important impact on outcomes and complication rates after shoulder arthroplasty for primary glenohumeral arthritis. The B2 glenoid, or a biconcave glenoid with posterior humeral head subluxation, in particular has been associated with a poorer outcome with shoulder arthroplasty compared with other glenoid types. A variety of techniques may be used to address the bone deficiency and instability seen with this glenoid type. Studies suggest that total shoulder arthroplasty may have a reasonable result in the short term but be associated with a high complication rate in the mid term because of recurrence of instability and early glenoid loosening when neoglenoid retroversion is greater than 27° or posterior humeral head subluxation is greater than 80%. Particularly in older patients with a substantial B2 deformity, primary reverse shoulder arthroplasty may be a more predictable means of addressing bone deficiency and restoring stability.
Copyright © 2013 Journal of Shoulder and Elbow Surgery Board of Trustees. Published by Mosby, Inc. All rights reserved.

Entities:  

Keywords:  B2 glenoid; Glenohumeral arthritis; Review Article; biconcave glenoid; glenoid erosion; posterior subluxation

Mesh:

Year:  2013        PMID: 24007651     DOI: 10.1016/j.jse.2013.06.017

Source DB:  PubMed          Journal:  J Shoulder Elbow Surg        ISSN: 1058-2746            Impact factor:   3.019


  29 in total

1.  Expanding roles for reverse shoulder arthroplasty.

Authors:  Peter N Chalmers; Jay D Keener
Journal:  Curr Rev Musculoskelet Med       Date:  2016-03

2.  The arthritic glenoid: anatomy and arthroplasty designs.

Authors:  Nikolas K Knowles; Louis M Ferreira; George S Athwal
Journal:  Curr Rev Musculoskelet Med       Date:  2016-03

Review 3.  Journey of the glenoid in anatomic total shoulder replacement.

Authors:  Alessandro Castagna; Raffaele Garofalo
Journal:  Shoulder Elbow       Date:  2018-08-01

4.  Soft tissue balancing in total shoulder replacement.

Authors:  Maike Mueller; Gregory Hoy
Journal:  Curr Rev Musculoskelet Med       Date:  2014-03

5.  "Shaped" humeral head autograft reverse shoulder arthroplasty : Treatment for primary glenohumeral osteoarthritis with significant posterior glenoid bone loss (B2, B3, and C type).

Authors:  S Harmsen; D Casagrande; T Norris
Journal:  Orthopade       Date:  2017-12       Impact factor: 1.087

6.  Anatomical total shoulder arthroplasty in young patients with osteoarthritis: all-polyethylene versus metal-backed glenoid.

Authors:  M O Gauci; N Bonnevialle; G Moineau; M Baba; G Walch; P Boileau
Journal:  Bone Joint J       Date:  2018-04-01       Impact factor: 5.082

7.  Risk of Perforation Is High During Corrective Reaming of Retroverted Glenoids: A Computer Simulation Study.

Authors:  Alexander W Aleem; Nathan D Orvets; Brendan C Patterson; Aaron M Chamberlain; Jay D Keener
Journal:  Clin Orthop Relat Res       Date:  2018-08       Impact factor: 4.176

Review 8.  Classifications in Brief: Walch Classification of Primary Glenohumeral Osteoarthritis.

Authors:  Kiet V Vo; Daniel J Hackett; Albert O Gee; Jason E Hsu
Journal:  Clin Orthop Relat Res       Date:  2017-03-17       Impact factor: 4.176

9.  Reverse total shoulder arthroplasty in patients with type B2, B3, and type C glenoids: comparable clinical outcome to patients without compromised glenoid bone stock-a matched pair analysis.

Authors:  Rafael Loucas; Philipp Kriechling; Marios Loucas; Rany El Nashar; Christian Gerber; Karl Wieser
Journal:  Arch Orthop Trauma Surg       Date:  2021-06-02       Impact factor: 3.067

10.  What Factors are Predictive of Patient-reported Outcomes? A Prospective Study of 337 Shoulder Arthroplasties.

Authors:  Frederick A Matsen; Stacy M Russ; Phuong T Vu; Jason E Hsu; Robert M Lucas; Bryan A Comstock
Journal:  Clin Orthop Relat Res       Date:  2016-07-25       Impact factor: 4.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.